Scientists develop nanoparticle-based biosensing device for rapid and ultrasensitive detection of SARS-CoV-2

Scientists from the University of Michigan, USA, have recently developed a gold nanoparticle-based biosensing device for rapid and ultrasensitive detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in point-of-care settings. The study is currently available on the medRxiv* preprint server.